Heron Therapeuti Stock Market Value
| HRTX Stock | USD 1.32 0.02 1.49% |
| Symbol | Heron |
Is Biotechnology space expected to grow? Or is there an opportunity to expand the business' product line in the future? Factors like these will boost the valuation of Heron Therapeuti. Market participants price Heron higher when confident in its future expansion prospects. The financial industry is built on trying to define current growth potential and future valuation accurately. Comprehensive Heron Therapeuti assessment requires weighing all these inputs, though not all factors influence outcomes equally.
The market value of Heron Therapeuti is measured differently than its book value, which is the value of Heron that is recorded on the company's balance sheet. Investors also form their own opinion of Heron Therapeuti's value that differs from its market value or its book value, called intrinsic value, which is Heron Therapeuti's true underlying value. Investors use various methods to calculate intrinsic value and buy a stock when its market value falls below its intrinsic value. Because Heron Therapeuti's market value can be influenced by many factors that don't directly affect Heron Therapeuti's underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Please note, there is a significant difference between Heron Therapeuti's value and its price as these two are different measures arrived at by different means. Investors typically determine if Heron Therapeuti is a good investment by looking at such factors as earnings, sales, fundamental and technical indicators, competition as well as analyst projections. Meanwhile, Heron Therapeuti's quoted price indicates the marketplace figure where supply meets demand through bilateral consent.
Heron Therapeuti 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Heron Therapeuti's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Heron Therapeuti.
| 11/03/2025 |
| 02/01/2026 |
If you would invest 0.00 in Heron Therapeuti on November 3, 2025 and sell it all today you would earn a total of 0.00 from holding Heron Therapeuti or generate 0.0% return on investment in Heron Therapeuti over 90 days. Heron Therapeuti is related to or competes with NeOnc Technologies, Invivyd, Protara Therapeutics, Sellas Life, Mediwound, Protalix Biotherapeutics, and Coherus BioSciences. Heron Therapeutics, Inc., a biotechnology company, engages in developing treatments to address unmet patient needs More
Heron Therapeuti Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Heron Therapeuti's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Heron Therapeuti upside and downside potential and time the market with a certain degree of confidence.
| Downside Deviation | 3.2 | |||
| Information Ratio | 0.0579 | |||
| Maximum Drawdown | 16.52 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 6.6 |
Heron Therapeuti Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Heron Therapeuti's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Heron Therapeuti's standard deviation. In reality, there are many statistical measures that can use Heron Therapeuti historical prices to predict the future Heron Therapeuti's volatility.| Risk Adjusted Performance | 0.0597 | |||
| Jensen Alpha | 0.1966 | |||
| Total Risk Alpha | 0.0658 | |||
| Sortino Ratio | 0.0583 | |||
| Treynor Ratio | 0.3083 |
Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Heron Therapeuti's price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Heron Therapeuti February 1, 2026 Technical Indicators
| Cycle Indicators | ||
| Math Operators | ||
| Math Transform | ||
| Momentum Indicators | ||
| Overlap Studies | ||
| Pattern Recognition | ||
| Price Transform | ||
| Statistic Functions | ||
| Volatility Indicators | ||
| Volume Indicators |
| Risk Adjusted Performance | 0.0597 | |||
| Market Risk Adjusted Performance | 0.3183 | |||
| Mean Deviation | 2.39 | |||
| Semi Deviation | 2.57 | |||
| Downside Deviation | 3.2 | |||
| Coefficient Of Variation | 1392.62 | |||
| Standard Deviation | 3.23 | |||
| Variance | 10.41 | |||
| Information Ratio | 0.0579 | |||
| Jensen Alpha | 0.1966 | |||
| Total Risk Alpha | 0.0658 | |||
| Sortino Ratio | 0.0583 | |||
| Treynor Ratio | 0.3083 | |||
| Maximum Drawdown | 16.52 | |||
| Value At Risk | (4.48) | |||
| Potential Upside | 6.6 | |||
| Downside Variance | 10.24 | |||
| Semi Variance | 6.59 | |||
| Expected Short fall | (3.20) | |||
| Skewness | 0.4674 | |||
| Kurtosis | 1.01 |
Heron Therapeuti Backtested Returns
Heron Therapeuti appears to be dangerous, given 3 months investment horizon. Heron Therapeuti holds Efficiency (Sharpe) Ratio of 0.0718, which attests that the entity had a 0.0718 % return per unit of risk over the last 3 months. We have found thirty technical indicators for Heron Therapeuti, which you can use to evaluate the volatility of the firm. Please utilize Heron Therapeuti's Downside Deviation of 3.2, risk adjusted performance of 0.0597, and Market Risk Adjusted Performance of 0.3183 to validate if our risk estimates are consistent with your expectations. On a scale of 0 to 100, Heron Therapeuti holds a performance score of 5. The company retains a Market Volatility (i.e., Beta) of 0.72, which attests to possible diversification benefits within a given portfolio. As returns on the market increase, Heron Therapeuti's returns are expected to increase less than the market. However, during the bear market, the loss of holding Heron Therapeuti is expected to be smaller as well. Please check Heron Therapeuti's potential upside, as well as the relationship between the accumulation distribution and price action indicator , to make a quick decision on whether Heron Therapeuti's current trending patterns will revert.
Auto-correlation | 0.22 |
Weak predictability
Heron Therapeuti has weak predictability. Overlapping area represents the amount of predictability between Heron Therapeuti time series from 3rd of November 2025 to 18th of December 2025 and 18th of December 2025 to 1st of February 2026. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Heron Therapeuti price movement. The serial correlation of 0.22 indicates that over 22.0% of current Heron Therapeuti price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.22 | |
| Spearman Rank Test | 0.63 | |
| Residual Average | 0.0 | |
| Price Variance | 0.01 |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Tools for Heron Stock Analysis
When running Heron Therapeuti's price analysis, check to measure Heron Therapeuti's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Heron Therapeuti is operating at the current time. Most of Heron Therapeuti's value examination focuses on studying past and present price action to predict the probability of Heron Therapeuti's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Heron Therapeuti's price. Additionally, you may evaluate how the addition of Heron Therapeuti to your portfolios can decrease your overall portfolio volatility.